EV Biologics (EV Biologics) EBIT per Share : $-0.60 (TTM As of Dec. 2017)

View and export this data going back to 2015. Start your Free Trial

What is EV Biologics EBIT per Share?

EV Biologics's EBIT per Share for the three months ended in Dec. 2017 was $-0.60. Its EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2017 was $-0.60.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for EV Biologics's EBIT per Share or its related term are showing as below:

YECO's 3-Year EBIT Growth Rate is not ranked ^*
in the Biotechnology industry.
Industry Median: 3.7
* Ranked among companies with meaningful 3-Year EBIT Growth Rate only.

EV Biologics's EBIT for the three months ended in Dec. 2017 was $-1.45 Mil.

EV Biologics EBIT per Share Historical Data

The historical data trend for EV Biologics's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

EV Biologics EBIT per Share Chart

EV Biologics Annual Data

Trend

Jun13

Jun14

Jun15

Jun16

Jun17

EBIT per Share

5.94

6.38

8.05

-20.46

-2.70

EV Biologics Quarterly Data
	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Jun17	Dec17
EBIT per Share	Get a 7-Day Free Trial												-25.26	-1.05	-102.30	-	-0.60

EV Biologics EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

EV Biologics's EBIT per Share for the fiscal year that ended in Jun. 2017 is calculated as

	EBIT per Share		(A: Jun. 2017 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-6.504	/	2.410
=	-2.70

EV Biologics's EBIT per Share for the quarter that ended in Dec. 2017 is calculated as

	EBIT per Share		(Q: Dec. 2017 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-1.445	/	2.410
=	-0.60

EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2017 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.60

EV Biologics (OTCPK:YECO) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

EV Biologics EBIT per Share Related Terms

Thank you for viewing the detailed overview of EV Biologics's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

EV Biologics (EV Biologics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » EV Biologics Inc (OTCPK:YECO) » Definitions » EBIT per Share

Comparable Companies

XCNQ:NIRV ENVB BLCM NLSP BRTX ADTX XKRX:066830 ALLR XMAD:ADL ARTL

Traded in Other Exchanges

N/A

Address

1621 Central Avenue, Cheyenne, WY, USA, 82001

Website

https://www.evbiologics.com

EV Biologics Inc is developing the extraordinary biological properties of extracellular vesicles (EVs) to create the next generation of diagnostic modalities and safe, effective biotherapeutics to improve outcomes of serious clinical conditions, increase natural longevity and transform lives.

Executives

Daniel S Mckinney	director, 10 percent owner, officer: CEO	TWO IFC, 19TH FLOOR, 8 FINANCE STREET, CENTRAL, HONG KONG F4 000000
Michael W Harlan	director	C/O WASTE CONNECTIONS, INC., 610 APPLEWOOD CRESCENT, SUITE 200, VAUGHAN A6 L4K 0C3